Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)

The global impact of SARS-CoV-2 on liver transplantation (LT) practices across the world is unknown. The goal of this survey was to assess the impact of the pandemic on global LT practices. A prospective web-based survey (available online from 7th September 2020 to 31st December 2020) was proposed t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2022-02, Vol.76 (2), p.364-370
Main Authors: Russo, Francesco Paolo, Izzy, Manhal, Rammohan, Ashwin, Kirchner, Varvara A., Di Maira, Tommaso, Belli, Luca Saverio, Berg, Thomas, Berenguer, Marina Carmen, Polak, Wojciech Grzegorz
Format: Article
Language:English
Subjects:
Blood & organ donations
Coronaviruses
COVID
COVID-19
COVID-19 - immunology
Cross-Sectional Studies
Global Health
Humans
Immunosuppression Therapy
Liver
Liver diseases
Liver Transplantation
Living Donors
Mortality
pandemic
Pandemics
Patients
Prospective Studies
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
survey
Telemedicine
Tissue and Organ Procurement
Transplants & implants
Waiting Lists
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The global impact of SARS-CoV-2 on liver transplantation (LT) practices across the world is unknown. The goal of this survey was to assess the impact of the pandemic on global LT practices. A prospective web-based survey (available online from 7th September 2020 to 31st December 2020) was proposed to the active members of the EASL-ESOT/ELITA-ILTS in the Americas (including North, Central, and South America) (R1), Europe (R2), and the rest of the world (R3). The survey comprised 4 parts concerning transplant processes, therapy, living donors, and organ procurement. Of the 470 transplant centers reached, 128 answered each part of the survey, 29 centers (23%), 64 centers (50%), and 35 centers (27%) from R1, R2, and R3, respectively. When we compared the practices during the first 6 months of the pandemic in 2020 with those a year earlier in 2019, statistically significant differences were found in the number of patients added to the waiting list (WL), WL mortality, and the number of LTs performed. At the regional level, we found that in R2 the number of LTs was significantly higher in 2019 (p
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2021.09.041